Possible rewritten summary:As the Strategy Lead External Innovation at Janssen Vaccines & Prevention, I am responsible for scouting, evaluating, and facilitating partnerships with external innovators in the vaccine field, with a focus on viral respiratory infections, HPV, and HSV-2. With a PhD in molecular and cellular biology and over 30 years of experience in academia and industry, I have a broad scientific interest in life sciences, disease, and global health, and a proven track record of leading successful vaccine projects.Previously, I led the global, cross-functional team that developed Johnson & Johnson's COVID-19 vaccine, which received regulatory approval or authorization for use in more than 100 countries, and was awarded the Johnson Medal, the most prestigious award for research and development in the corporation. I also led the therapeutic HPV vaccine program, which aims to treat high-risk HPV infections that can cause cervical cancer. I value diversity, clear communication, and collaboration in my teams, and I am motivated by the opportunity to make a positive impact on public health through innovation and excellence.
Listed skills include Genetics, Research, Lifesciences, Cell, and 8 others.